IMAC Holdings, Inc.

BACK

US44967K3023

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 01:30:00 26/06/2024 am IST			5-day change	1st Jan Change
2.56 ^USD	-0.39%		+13.27%	+15.84%

25/06	DDC Enterprise, Ltd. Appoints Jeffrey Ervin as Co-Chief Financial Officer	CI
18/06	IMAC Holdings, Inc. announced that it has received $1 million in funding	CI

IMAC Holdings, Inc. announced that it has received $0.45 million in funding

May 14, 2024

On May 14, 2024, IMAC Holdings, Inc. closed the transaction.

Latest news about IMAC Holdings, Inc.

DDC Enterprise, Ltd. Appoints Jeffrey Ervin as Co-Chief Financial Officer	25/06	CI
IMAC Holdings, Inc. announced that it has received $1 million in funding	18/06	CI
IMAC Holdings Names Faith Zaslavsky as CEO	24/05	MT
IMAC Holdings, Inc. Announces Board Resignations	24/05	CI
IMAC Holdings, Inc. Announces Chief Executive Officer Changes	24/05	CI
IMAC Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
IMAC Holdings, Inc. announced that it has received $0.45 million in funding	14/05	CI
IMAC Holdings, Inc. announced that it expects to receive $0.45 million in funding	13/05	CI
IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc.	07/05	CI
Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.	06/05	CI
IMAC Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	17/04	CI
IMAC Holdings, Inc. announced that it expects to receive $0.9 million in funding from District 2 Capital LP, Ashton Capital Corporation, Cavalry Fund I Management, LLC, Kips Bay Select LP, Walleye Capital LLC, Lincoln Park Capital, LLC	10/04	CI
Top Premarket Decliners	28/12	MT
IPM Medical Group, Inc. acquired IMAC Regeneration Center in Arlington Heights, Illinois from IMAC Holdings, Inc..	12/12	CI
IMAC Holdings, Inc. Announces Executive Changes	01/12	CI
The Regenerative Center, LLC acquired Tangible and intangible assets of Kentucky operation of IMAC Holdings, Inc. for $0.08 million.	30/11	CI
IMAC Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11	CI
IMAC Holdings Regains Compliance With Nasdaq Listing Rule	28/23/28	MT
Labor Data, Inflation Woes Weigh on Exchange-Traded Funds, Equity Futures Premarket Friday	08/23/08	MT
IMAC Holdings Implements 1-for-30 Reverse Stock Split	08/23/08	MT
IMAC Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/23/22	CI
IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors	26/23/26	CI
IMAC, Theralink Technologies Sign Merger Deal; IMAC Shares Jump	23/23/23	MT
IMAC Holdings, Inc. Appoints Jeffrey Busch to Serve as Chairman	23/23/23	CI
IMAC Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	20/23/20	CI

IMAC Holdings, Inc. is a clinical research and commercialization company. The Company is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The Company is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinsonâs disease. The Company is also engaged in providing the precision medicine business. The Company's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDTs are utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.

Sector

Healthcare Facilities & Services

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.56 USD

Average target price

8.25 USD

Spread / Average Target

+222.27%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
IMAC HOLDINGS, INC.	+15.84%	29.4L
AIER EYE HOSPITAL GROUP CO., LTD.	-32.87%	1.34TCr
IHH HEALTHCARE	+4.15%	1.17TCr
BANGKOK DUSIT MEDICAL SERVICES	-3.60%	1.16TCr
APOLLO HOSPITALS ENTERPRISE LIMITED	+8.66%	1.08TCr
ENCOMPASS HEALTH CORPORATION	+27.20%	854.58Cr
RAMSAY HEALTH CARE LIMITED	-11.44%	723.89Cr
THE ENSIGN GROUP, INC.	+7.99%	684.24Cr
MOUWASAT MEDICAL SERVICES COMPANY	+9.12%	650.35Cr
FORTIS HEALTHCARE LIMITED	+15.46%	438.77Cr

Hospitals, Clinics & Primary Care Services